Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry

Clinical Chemistry

Volumn 51, Issue 5, 2005, Pages 872-877

  Annesley, Thomas M ^a,b   Clayton, Larry T ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Urology Institute Case Medical Center University Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ETHER; GLUCURONIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID CARBOXYBUTOXY ETHER; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ACCURACY; ACIDIFICATION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; INTERMETHOD COMPARISON; ORGAN TRANSPLANTATION; REGRESSION ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; ORGAN TRANSPLANTATION; SERUM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 17744386925     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.047357     Document Type: Article

References (15)

1. Bullingham RE, Nicholls AG, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998;34:429-55.
2. Kaplan B, Gruber SA, Nallamathou R, Katz SM, Shaw LM. Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. Transplantation 1998;65:1127-9.
3. Weber LT, Shipkova M, Armstrong VW, Wagner N, Schutz E, Mehls O, et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002;13:759-68.
4. Willis C, Taylor PJ, Salm P, Tett SE, Pillans PI. Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B 2000;748:151-6.
5. Atcheson B, Taylor PJ, Mudge DW, Johnson DW, Pillans PI, Tett SE. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J Chromatogr B 2004;799:157-63.
6. Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T, et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr B 2004;813:287-94.
7. Streit F, Shipkova M, Armstrong VW, Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin Chem 2004;50:152-9.
8. Premaud A, Rousseau A, Le Meur Y, Lachatre G, Marquet P. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther Drug Monit 2004; 26:609-19.
9. Annesley TM, Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin Chem 2004;50: 1845-8.
10. Bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, 2001.
11. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm Res 2000;17:1551-7.
12. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices. NCCLS Document EP5-T2. Wayne, PA: NCCLS, 1992.
13. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4.
14. Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, et al. Therapeutic monitoring of mycophenolic acid: a consensus report. Clin Biochem 1998;31:317-22.
15. Vogeser M, Zachoval R, Spohrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit 2001; 23:722-4.